Disclaimer: this software uses AI to aggregate and filter content. Please double-check sources before putting info to action.
📰 News Media
- 💉 [Pueblo, Colorado] Syringe litter did not increase after a needle exchange ban was overturned in Pueblo, Colorado, but health services suffered - theconversation.com
- 🏪 [Los Angeles, CA] L.A. takes aim at phenibut, an unregulated 'gas station drug' that is growing in popularity - latimes.com
- 🏙️ [Burlington, VT] Burlington looks to the state for help combating homelessness and drug use downtown - vtdigger.org
- 🏥 [National] Addiction Treatment Providers Navigate Rising Federal Scrutiny on Fraud - bhbusiness.com
- 🌿 [National] Americans Encounter Risks at Psychedelic Clinics Abroad - nytimes.com
🗣️ Social Pulse
Lived/Living Experience
Innovation
- 📊 Evaluating the effects of policy interventions subject to early adoption: A case study of prescription drug monitoring programs and opioid dispensing Sarika Aggarwal, Brent A. Coull, Nima Hejazi, Rachel C. Nethery... - @StatisticsME on X
- 🤝 “Funding from the opioid settlement allowed us to partner with CSC to break down traditional barriers to care. We’ve been able to embed a staff member directly in the community for the first time... This... - @triciac13 on LinkedIn
Opposition Views
- No posts found today.
🏙 City Updates
- No recent City Updates found.
📚 Academic Research
- 🩺 Burnout and coping among professionals working in a drug consumption room: a qualitative study - Harm Reduction Journal - 2026-08-25 - doi.org
- 🚑 Compassionate Overdose Response: Experiences of Overdose Survivors in New York City (Preprint) - 2026-08-25 - doi.org
- 🧑 Predictors of Early Retention in Peer Recovery Program for Justice-Involved Individuals With Opioid Use Disorder - Journal of Correctional Health Care - 2026-08-25 - doi.org
⚖️ Law & Policy
Federal Agencies
- 🧪 [United States] [Comment Request] Hydroxymitragynine Above a Specified Threshold in Schedule I; Extension of Comment Period - federalregister.gov
- 🧪 [United States] [Final Rule] Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I - federalregister.gov
💸 Funding
Current
- Deadline Approaching🚑 Office of National Drug Control Policy - Nonfatal Overdoses in Emergency Departments: Bridging Patient Characteristics, Biospecimen Toxicology, and Drug Supply Composition - Deadline: Aug 31, 2026
- 💊 Bureau of Justice Assistance - BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Site-Based Program - Deadline: Sep 24, 2026
- 🔬 National Institutes of Health - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) - Deadline: Sep 30, 2026
- 🔬 National Institutes of Health - Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed) - Deadline: Oct 1, 2026
- 🔬 National Institutes of Health - Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) - Deadline: Aug 21, 2028
- 🔬 National Institutes of Health - Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) - Deadline: Sep 25, 2028
- 🔬 National Institutes of Health - HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) - Deadline: Feb 9, 2029
- 🩺 Hearst Foundations - Health - Hearst Foundations (Health) — General Application (Year-round, Rolling) - Minimum grant size is $100,000. Types and amounts are referenced via the Grant Recipients Database. - Deadline: Year-round, rolling application; there are no deadlines.
- 💡 Smart Family Fund - First time grants range from $25,000 to $100,000. - Deadline: Open pitch